Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Name | Co-amoxiclav 500mg/125mg tablets |
BNF code | 0501013K0AAAJAJ |
Virtual Therapeutic Moiety | Co-amoxiclav |
Date identifier became valid | 27 May 2021 |
Previous product identifier | 323539009 |
Basis of preferred name | BAN - British Approved Name |
Date of name applicability | 4 May 2004 |
Previous name | Co-amoxiclav 500/125 tablets |
Basis of previous name | BAN - British Approved Name |
Reason for name change | |
Prescribing status | Valid as a prescribable product |
Sugar free | ✗ |
Gluten free | ✗ |
Preservative free | ✗ |
CFC free | ✗ |
Dose form | Discrete |
Unit dose form size | 1.000 |
Unit dose form units | tablet |
Unit dose unit of measure | tablet |
Virtual Product Ingredient | |
---|---|
Ingredient | Amoxicillin trihydrate |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 372687004 |
Strength value numerator | 500.000 |
Strength value numerator unit | mg |
Virtual Product Ingredient | |
Ingredient | Potassium clavulanate |
Basis of pharmaceutical strength | Based on Base Substance |
Basis of strength substance identifier | 395939008 |
Strength value numerator | 125.000 |
Strength value numerator unit | mg |
Ontology Drug Form & Route | |
Form & Route | tablet.oral |
Dose Form | |
Formulation | Oral tablet |
Drug Route | |
Route | Oral |
Controlled Drug Prescribing Information | |
Controlled Drug category | No Controlled Drug Status |
Actual Medicinal Products | |
Augmentin 625mg tablets (GlaxoSmithKline UK Ltd) | |
Augmentin 625mg tablets (Lexon (UK) Ltd) | |
Augmentin 625mg tablets (Sigma Pharmaceuticals Plc) | |
Co-amoxiclav 500mg/125mg tablets (A A H Pharmaceuticals Ltd) | |
Co-amoxiclav 500mg/125mg tablets (Alliance Healthcare (Distribution) Ltd) | |
Co-amoxiclav 500mg/125mg tablets (Almus Pharmaceuticals Ltd) | |
Co-amoxiclav 500mg/125mg tablets (Bristol Laboratories Ltd) | |
Co-amoxiclav 500mg/125mg tablets (Brown & Burk UK Ltd) | |
Co-amoxiclav 500mg/125mg tablets (Medihealth (Northern) Ltd) | |
Co-amoxiclav 500mg/125mg tablets (Medreich Plc) | |
Co-amoxiclav 500mg/125mg tablets (Milpharm Ltd) | |
Co-amoxiclav 500mg/125mg tablets (Noumed Life Sciences Ltd) | |
Co-amoxiclav 500mg/125mg tablets (Phoenix Healthcare Distribution Ltd) | |
Co-amoxiclav 500mg/125mg tablets (Rivopharm (UK) Ltd) | |
Co-amoxiclav 500mg/125mg tablets (Sandoz Ltd) | |
Co-amoxiclav 500mg/125mg tablets (Sigma Pharmaceuticals Plc) | |
Co-amoxiclav 500mg/125mg tablets (Sun Pharma UK Ltd) | |
Virtual Medicinal Product Packs | |
Co-amoxiclav 500mg/125mg tablets 100 tablet | |
Co-amoxiclav 500mg/125mg tablets 12 tablet | |
Co-amoxiclav 500mg/125mg tablets 15 tablet | |
Co-amoxiclav 500mg/125mg tablets 21 tablet | |
Co-amoxiclav 500mg/125mg tablets 24 tablet |
dm+d data retrieved from TRUD: release NHSBSA_11.2.0_20241118000001, imported on 19th November 2024 at 03:53:26.